Cryopyrin Associated Periodic Syndrome
Cryopyrin Associated Periodic Syndrome (CAPS) is a rare autoinflammatory condition that leads to recurrent episodes of fever, rash, and joint pain due to an abnormal response of the immune system.
We are investigating a new compound, NT 0150, for its safety and how it is absorbed and eliminated in the body. This research may help in developing treatments for Alzheimer's and Parkinson's disease.
Health conditions and diseases that the clinical trial is designed to study and treat.
Cryopyrin Associated Periodic Syndrome (CAPS) is a rare autoinflammatory condition that leads to recurrent episodes of fever, rash, and joint pain due to an abnormal response of the immune system.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.